Page 5 - 2019_08-Haematologica-web

Table of Contents
Volume 104, Issue 8: August 2019
Cover Figure
haematologica Journal of the Ferrata Storti Foundation
Bone marrow smear showing a giant plasmablast with two macronucleoli and deeply basophilic cytoplasm with Immunoglobulin accu- mulation in the form of amorphous substance or crystals in a patient with plasma cell myeloma. Courtesy of Prof. Rosangela Invernizzi.
Editorials
1503 Does iron let boys grow faster?! Günter Weiss
1505 The wolf of hypomethylating agent failure: what comes next? Anne Sophie Kubasch and Uwe Platzbecker
1508 Discontinuation of tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: it may be easier than you think Charles A. Schiffer
1511 The only thing that stops a bad microbiome, is a good microbiome Jessica R. Galloway-Peña and Robert R. Jenq
1513 Predicting risk for recurrence of arterial ischemic stroke in children: thrombophilia as another piece of the puzzle Ghada Aborkhees and Lesley Gayle Mitchell
Perspective Article
1515 “Somatic” and “pathogenic” - is the classification strategy applicable in times of large-scale sequencing? Constance Baer et al.
Review Articles
1521 Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?
Brian Ball and Eytan M. Stein
1532 How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia? Nicholas J. Short and Farhad Ravandi
Articles
Iron Metabolism & its Disorders
1542 Rapid growth is a dominant predictor of hepcidin suppression and declining ferritin in Gambian infants Andrew E. Armitage et al.
Red Cell & its Disorders
1554 Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients Véronique Picard et al.
Myelodysplastic Syndromes
1565 A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
Marie Sébert et al.
Myeloproliferative Neoplasms
1572 Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated
Nicolás Martínez-Calle et al.
Haematologica 2019; vol. 104 no. 8 - August 2019 http://www.haematologica.org/